Notice of Adaltis 2006 fourth quarter and year end financial results conference call

    MONTREAL, March 26 /CNW Telbec/ - Adaltis Inc. (TSX: ADS), an
international in vitro diagnostic company, will release its 2006 fourth
quarter and year end financial results on Tuesday, March 27, 2007 at
1:00 p.m. ET. Following the release, a conference call for investors is
scheduled to be held at 5:00 p.m. ET. Mr. Pierre Larochelle, President and
Chief Executive Officer, Mr. Jacques Deforges, Vice President, Finance and
Chief Financial Officer, and Dr. Raymond Tong, Chief Operating Officer, will
participate in the conference call.

    Conference call details:

    Date:                    Tuesday, March 27, 2007

    Time:                    5:00 p.m. ET

    Dial-in number:          (800) 810-0924 (Canada/US) or
                             (913) 981-4900 (International)

    Live audio sound cast:   Adaltis' Web site, "Investor Relations" section

    If you are unable to participate in the conference call, a replay will be
available starting that same day at 6:00 p.m. ET by dialing (888) 203-1112
(Canada and United States) or (719) 457-0820 (International) and entering
passcode #6419829, until April 3, 2007 at midnight or by audio sound cast on
Adaltis' Web site for 90 days.

    About Adaltis

    Adaltis is an international in vitro diagnostic company that develops,
manufactures and markets diagnostic systems. It aims to leverage its
experience in Europe to become a leading provider of in vitro diagnostic
products in emerging markets, with a particular focus on China.
    With the assistance of its two strategic shareholders, CITIC Pacific
Limited (a large Hong Kong-based conglomerate) and Picchio Pharma Inc. (a
joint venture healthcare investment firm owned by FMRC Family Trust (a trust
of which Dr. Francesco Bellini is a beneficiary), and Power Technology
Investment Corporation, a subsidiary of Power Corporation of Canada), Adaltis
has completed building its manufacturing facility in Shanghai. Now
operational, the production facility manufactures high-quality products in a
low-cost GMP environment, in order to service existing markets in Europe,
while providing a platform to penetrate the high-growth Chinese in vitro
diagnostic market.
    Adaltis is headquartered in Montreal, with offices in China, Hong Kong,
Italy, Germany and Mexico.

For further information:

For further information: please contact: Jacques Deforges, Vice
President, Finance and Chief Financial Officer, Adaltis Inc., (514) 335-9922,
ext. 245,; Eddy Miller, Director, Investor
Relations, Adaltis Inc., (514) 335-9922, ext. 257,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890